{
    "clinical_study": {
        "@rank": "37160", 
        "brief_summary": {
            "textblock": "The REFLEx Study will evaluate if ENDOTAK RELIANCE G defibrillation leads with GORE\n      ePTFE-covered coils are as good as or better than other comparative commercially available\n      defibrillation leads with respect to electrical performance and termination efficacy in\n      spontaneous tachyarrhythmic episodes."
        }, 
        "brief_title": "REFLEx Study (ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance", 
        "completion_date": "March 2006", 
        "condition": "Arrhythmia", 
        "condition_browse": {
            "mesh_term": "Arrhythmias, Cardiac"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who meet current ICD or CRT-D indications\n\n          -  Patients who are going to be implanted with one of the aforementioned ICD or CRT-D\n             devices\n\n          -  Patients who are going to be implanted with active-fixation, dual-coil, endocardial\n             defibrillation leads with compatible connectors (i.e., ENDOTAK RELIANCE G or\n             study-comparative ICD leads)\n\n          -  Patients who sign and date a Patient Informed Consent form prior to device implant\n\n          -  Patients who remain in the clinical care of the enrolling physician in approved\n             centers\n\n          -  Patients who are at least 18 years old\n\n        Exclusion Criteria:\n\n          -  Patients who have a preexisting transvenous lead system that is not completely\n             explanted\n\n          -  Patients who are hypersensitive to a single dose of approximately 1.0 mg of\n             dexamethasone acetate\n\n          -  Patients who are expected to receive a heart transplant during the duration of the\n             study\n\n          -  Patients whose estimated life expectancy is less than 12 months due to other medical\n             conditions\n\n          -  Patients who currently have or who are likely to receive a tricuspid valve prosthesis\n\n          -  Patients who are likely to have an open-chest surgery in the next three months\n\n          -  Patients who are currently enrolled in another investigational study that would\n             directly impact the treatment or outcome of the REFLEx study.\n\n          -  Patients who are mentally incompetent and cannot sign a Patient Informed Consent form\n             or comply with the study\n\n          -  Patients who are pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "1500", 
        "firstreceived_date": "September 2, 2005", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00146822", 
            "org_study_id": "CR-CA-022504-L"
        }, 
        "intervention": {
            "intervention_name": "ENDOTAK RELIANCE G lead", 
            "intervention_type": "Device"
        }, 
        "lastchanged_date": "November 13, 2006", 
        "official_title": "ENDOTAK RELIANCE\uf0e2 G Evaluation of Handling and Electrical Performance Study", 
        "overall_official": {
            "affiliation": "Wake Heart Associates", 
            "last_name": "Randolph Cooper, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "Phase 4", 
        "primary_outcome": [
            {
                "measure": "Lead electrical properties"
            }, 
            {
                "measure": "First shock conversion success rate for spontaneous fast ventricular tachycardia or ventricular fibrillation"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00146822"
        }, 
        "secondary_outcome": [
            {
                "measure": "Lead handling characteristics"
            }, 
            {
                "measure": "Lead migration/dislodgment rates"
            }, 
            {
                "measure": "Characterize the current ICD/CRT-D population"
            }, 
            {
                "measure": "Effects of ischemia and revascularization and previous lead extraction on the lead\u2019s electrical performance"
            }
        ], 
        "source": "Boston Scientific Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boston Scientific Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2004", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind", 
        "study_type": "Interventional", 
        "verification_date": "April 2006"
    }
}